Literature DB >> 7917877

Steroid-sparing effect of mizoribine in long-term nephrotic syndrome of children.

Y Igarashi, Y Moro, Y Kondo, C N Inoue.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917877     DOI: 10.1007/bf00866378

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Studies on bredinin. I. Isolation, characterization and biological properties.

Authors:  K Mizuno; M Tsujino; M Takada; M Hayashi; K Atsumi
Journal:  J Antibiot (Tokyo)       Date:  1974-10       Impact factor: 2.649

2.  Advantages of triple therapy with mizoribine, cyclosporine and prednisolone over other types of triple and/or double therapy including cyclosporine for renal transplantation.

Authors:  H Uchida; K Mita; Y Bekku; Y Nishimura; Y Ishida; K Watanabe; S Tomikawa; S Inoue; H Sugimoto; T Nagao
Journal:  J Toxicol Sci       Date:  1991-11       Impact factor: 2.196

3.  A case of recurrent lupus nephritis after renal transplantation.

Authors:  K Kumano; T Sakai; S Mashimo; T Endo; K Koshiba; J S Elises; K Iitaka
Journal:  Clin Nephrol       Date:  1987-02       Impact factor: 0.975

  3 in total
  2 in total

1.  Maintenance treatment using the purine-synthesis inhibitor mizoribine in a patient with relapsing thrombotic thrombocytopenic purpura.

Authors:  Tetsuya Kawamura; Joichi Usui; Kei Nagai; Kentaro Sakai; Itaru Ebihara; Kunihiro Yamagata
Journal:  CEN Case Rep       Date:  2017-11-09

2.  Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).

Authors:  Taketsugu Hama; Koichi Nakanishi; Kenji Ishikura; Shuichi Ito; Hidefumi Nakamura; Mayumi Sako; Mari Saito-Oba; Kandai Nozu; Yuko Shima; Kazumoto Iijima; Norishige Yoshikawa
Journal:  BMC Nephrol       Date:  2018-09-10       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.